Biology Reference
In-Depth Information
51 Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC, Kossmann T, Trentz
O, Bauer C (1997) Detection of erythropoietin in human liquor: Intrinsic erythropoietin produc-
tion in the brain.
Kidney Int
51: 416-418
52 Yoshimura A, Longmore G, Lodish HF (1990) Point mutation in the exoplasmic domain of the
erythropoietin receptor resulting in hormone-independent activation and tumorigenicity.
Nature
348: 647-649
53 Elliott S, Lorenzini T, Yanagihara D, Chang D, Elliott G (1996) Activation of the erythropoietin
(EPO) receptor by bivalent anti-EPO receptor antibodies.
J Biol Chem
271: 24691-24697
54Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett
RW, Jolliffe LK, Dower WJ (1996) Small peptides as potent mimetics of the protein hormone ery-
thropoietin.
Science
273: 458-464
55 Qureshi SA, Kim RM, Konteatis Z, Biazzo DE, Motamedi H, Rodrigues R, Boice JA, Calaycay
JR, Bednarek MA, Griffin P et al. (1999) Mimicry of erythropoietin by a nonpeptide molecule.
Proc Natl Acad Sci USA
96: 12156-12161
56 Goldberg J, Jin Q, Ambroise Y, Satoh S, Desharnais J, Capps K, Boger DL (2002) Erythropoietin
mimetics derived from solution phase combinatorial libraries.
J Am Chem Soc
124: 544-555
57Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang
J et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor
orientation.
Nature
395: 511-516
58 Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe
LK, Wilson IA (1996) Functional mimicry of a protein hormone by a peptide agonist: The EPO
receptor complex at 2.8 A.
Science
273: 464-471
59Wrighton NC, Balasubramanian P, Barbone FP, Kashyap AK, Farrell FX, Jolliffe LK, Barrett RW,
Dower WJ (1997) Increased potency of an erythropoietin peptide mimetic through covalent dimer-
ization.
Nat Biotechnol
15: 1261-1265
60 Kuai L, Wu C, Qiu Q, Zhang J, Zhou A, Wang S, Zhang H, Song Q, Liao S, Han Y et al. (2000)
Plasminogen activator inhibitor-1 fused with erythropoietin (EPO) mimetic peptide (EMP)
enhances the EPO activity of EMP.
J Peptide Res
56: 59-62
61 McConnell SJ, Dinh T, Le MH, Brown SJ, Becherer K, Blumeyer K, Kautzer C, Axelrod F,
Spinella DG (1998) Isolation of erythropoietin receptor agonist peptides using evolved phage
libraries.
Biol Chem
379: 1279-1286
62 Naranda T, Kaufman RI, Li J, Wong K, Boge A, Hallen D, Fung KY, Duncan MW, Andersen N,
Goldstein A et al. (2002) Activation of erythropoietin receptor through a novel extracellular bind-
ing site.
Endocrinology
143: 2293-2302
63 Biazzo DE, Motamedi H, Mark DF, Qureshi SA (2000) A high-throughput assay to identify com-
pounds that can induce dimerization of the erythropoietin receptor.
Anal Biochem
278: 39-45
64 Tian SS, Lamb P, King AG, Miller SG, Kessler L, Luengo JI, Averill L, Johnson RK, Gleason JG,
Pelus LM et al. (1998) A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor.
Science
281: 257-259
65 Zhang B, Salituro G, Szalkowski D, Li Z, Zhang Y, R o yo I, Vilella D, Diez MT, Pelaez F, Ruby C
et al. (1999) Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.
Science
284: 974-977
66 Qureshi SA, Ding V, Li Z, Szalkowski D, Biazzo-Ashnault DE, Xie D, Saperstein R, Brady E,
Huskey S, Shen X et al. (2000) Activation of insulin signal transduction pathway and anti-diabet-
ic activity of small molecule insulin receptor activators.
J Biol Chem
275:36590-36595
67 Constantinescu SN, Liu X, Beyer W, Fallon A, Shekar S, Henis YI, Smith SO, Lodish HF (1999)
Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a
single amino acid in its transmembrane domain.
EMBO J
18: 3334-3347
68 Li JP, Hu HO, Niu QT, Fang C (1995) Cell surface activation of the erythropoietin receptor by
Friend spleen focus-forming virus gp55.
J Virol
69: 1714-1719
69 Sharlow ER, Pacifici R, Crouse J, Batac J, Todokoro K, Wojchowski DM (1997) Hematopoietic
cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in ery-
throleukemic SKT6 cells.
Blood
90: 2175-2187
70 Yi T, Zhang J, Miura O, Ihle JN (1995) Hematopoietic cell phosphatase associates with erythro-
poietin (EPO) receptor after EPO-induced receptor tyrosine phosphorylation: Identification of
potential binding sites.
Blood
85: 87-95
71 Watowich SS, Xie X, Klingmuller U, Kere J, Lindlof M, Berglund S, del la Chapelle A (1999b)
Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to
